The FDA granted approval to Abbott’s NDA for Simcor, a fixed-dose combination of Niaspan (extended-release niacin) and simvastatin, the generic version of Merck’s Zocor. The drug is indicated to raise ...

SIMCOR was approved by the FDA in February 2008 in the following strengths: 500/20 mg, 750/20 mg and 1,000/20 mg. The original FDA approval was supported by results from the SEACOAST trial, which ...

Niacin extended-release 500 mg, simvastatin 20 mg; tabs. Simcor combines the HMG-CoA reductase inhibitor, simvastatin, and the nicotinic acid derivative, extended-release niacin (Niaspan, also from ...

FDA approves Simcor for cholesterol treatment Abbott has received FDA approval for Simcor, a fixed-dose, single-pill combination of two cholesterol-lowering medications: Niaspan (niacin ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. (Reuters) - Abbott Laboratories asked a federal court to ...

SIMCOR is used along with diet to lower levels of total cholesterol, LDL "bad" cholesterol and triglycerides, and to increase HDL "good" cholesterol. SIMCOR is used when treatment with simvastatin ...

MORRISTOWN, N.J., May 5 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida ...

Abbott Laboratories has received approval from US regulators for Simcor, the latest combination drug to be given the go-ahead as a treatment for cholesterol. Abbott Laboratories has received approval ...

ABBOTT PARK, Ill., Dec. 10 Abbott (NYSE: ABT) has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR®, a ...

ABBOTT PARK, Ill., July 28 Abbott (NYSE: ABT) today received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR®, a cholesterol medication. The new SIMCOR dosage ...